Mankind Pharma Ltd.

NSE: MANKIND | BSE: 543904 | ISIN: INE634S01028 | Industry: Pharmaceuticals
| Expensive Performer
2356.7000 4.30 (0.18%)
NSE Jun 09, 2025 15:31 PM
Volume: 324.3K
 

2356.70
0.18%
Motilal Oswal
Mankind Pharma (Mankind) delivered in-line revenue in 4QFY25; however, EBITDA/PAT came in 14%/12% below our estimates. Higher-than-expected spending on marketing and promotional activities affected the company’s 4Q performance.
Mankind Pharma Ltd. is trading below all available SMAs
More from Mankind Pharma Ltd.
Recommended